CLINICAL SUPPLY MANAGEMENT ARTICLES
Who Decides When The Comparator Changes?
Clinical trial comparator sourcing can affect patient treatment and study design. Learn when comparator changes become clinical decisions and who should own them.
CLINICAL SUPPLY MANAGEMENT RESOURCES
-
Uncover the ways interactive response technologies are helping trial sponsors manage the distribution of medications, forecast trial supply, and integrate workflows with other technology platforms.
-
Drive excellence in clinical trials by utilizing forecasting to better plan clinical supply budgets and project timelines, and identify potential supply-related issues before they negatively impact a study.
-
By offering guidance on optimizing ROI from extensive data collections and various endpoints in clinical studies, learn how IRT technology can enhance the data-driven approach for sponsors.
-
Discover what happened when the Fountayn Platform, including RTSM, was used to support a client’s two-year, Phase III study seeking a cure for multiple sclerosis.
-
A pharma company used Signant Health's RTSM solution in a Phase 2 schizophrenia trial to ensure drug availability, maintain study balance, prevent duplicate allocations, and manage returns and destruction of unused drugs.
-
This comprehensive guide provides practical insights and best practices for ensuring the timely, secure, and reliable delivery of clinical trial materials worldwide.
-
Gain insight into the changing comparator sourcing landscape, focusing specifically on the instrumental role the Bolar exemption plays in the shift away from dependence on innovators for clinical supplies.